Effectiveness of Aflibercept in a Case of TASS-Associated Macular Edema

Özet

Toxic anterior segment syndrome (TASS) is an acute, non-infectious postoperative inflammatory reaction of the anterior segment of the eye, that usually develops 12-48 hours after intraocular surgery. Mostly, the inflammation is resolved with appropriate treatment within days or weeks, with a good outcome; however, infrequently complications such as permanent corneal edema, secondary glaucoma, and chronic macular edema can occur jeopardizing the visual outcome. The aim of this study is to present the clinical outcomes of intravitreal aflibercept injection in a case with macular edema associated with TASS. Keywords: Macular edema, Toxic anterior segment syndrome.